Skip to main content
Log in

18F-fluorodeoxyglucose-PET and99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

In a patient with the occipitoparietal form of Creutzfeldt-Jakob disease (CJD) (Heidenhain type) positron emission tomography (PET) demonstrated decreased glucose utilization in the occipital lobes and adjacent cortical regions. Single photon emission computed tomography (SPECT) with99mTc-bicisate showed a “coupled” decrease in blood flow in identical cortical areas in this patient. In contrast, magnetic resonance imaging (MRI) was normal. In the early stage of CJD, when still no major morphological abnormalities can be observed, functional imaging is useful for differential diagnosis, particularly to exclude other causes of dementia or pathological EEG patterns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases.Ann Neurol 20: 597–602, 1986.

    Article  CAS  PubMed  Google Scholar 

  2. Prusiner SB, De Armond SJ. Prion diseases of the central nervous system.Monogr Pathol 32: 86–122, 1990.

    PubMed  Google Scholar 

  3. Brown P, Goldfarb LG, Gajdusek DC. The new biology of spongiform encephalopathy: infectious amyloidosis with a genetic twist.Lancet 337: 1019–1022, 1991.

    Article  CAS  PubMed  Google Scholar 

  4. Fraser H, Dickinson AG. Targeting of scrapie lesions and spread of agent via the retino-tectal projection.Brain Res 346: 32–41, 1985.

    Article  CAS  PubMed  Google Scholar 

  5. Ter Meulen V, Kiessling WR. Slow-Virus-Erkrankungen des Menschen.In Neurologie in Praxis und Klinik, Hopf HC, Poeck K, Schliak H (eds.), 2nd ed., Stuttgart-New York, Georg Thieme Verlag, pp. 8.57–8.64, 1992.

    Google Scholar 

  6. Holman BL, Carvalho PA, Zimmermann RE, Johnson KA, Tumeh SS, Smith AP, et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience.J Nucl Med 31: 1456–1561, 1990.

    CAS  PubMed  Google Scholar 

  7. Heidenhain A. Klinische und anatomische Untersuchungen über eine eigenartige Erkrankung des Zentralnervensystems im Praesenium.Z Ges Neurol Psychiat 118: 49, 1929.

    Article  Google Scholar 

  8. Jones HR, Hedley-Whyte ET, Freidberg SR, Baker RA. Ataxic Creutzfeldt Jakob disease: diagnostic techniques and neuropathologic observation in early disease.Neurology 35: 254–257, 1985.

    PubMed  Google Scholar 

  9. Norstrand IF. Cerebral disorders detected by EEG and missed by CAT scan.Clinical EEG 13: 139–147, 1982.

    CAS  Google Scholar 

  10. Galvez S, Cartier L, Computed tomography findings in 15 cases of Creutzfeldt-Jakob disease with histological verification.J Neurol Neurosurg Psychiatry 47: 1244–1246, 1984.

    Article  CAS  PubMed  Google Scholar 

  11. Shin WJ, Markesbery WR, Clark DB, Goldstein S, Domstadt PA, Coupai JJ, et al. Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease).J Nucl Med 28: 1484–1487, 1987.

    Google Scholar 

  12. Jibiki I, Fukushima T, Kobayashi K, Kurokawa K, Yamaguchi N, Matsuda H, et al. Utility of I-123-IMP SPECT brain scans for the early detection of site-specific abnormalities in Creutzfeldt-Jakob disease (Heidenhain type): a case study.Neuropsychobiology 29: 117–119, 1994.

    Article  CAS  PubMed  Google Scholar 

  13. Goto 1, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A. Positron emission tomography (PET) studies in dementia.J Neurol Sci 114: 1–6, 1993.

    Article  CAS  PubMed  Google Scholar 

  14. Shishido F, Uemura K, Inugami A, Tomura N, Higano S, Fujita H, et al. Brain glucose metabolism in a patient with Creutzfeldt-Jakob disease measured by positron emission tomography.KAKU IGAKU (Jpn J Nucl Med) 27: 649–654, 1990.

    CAS  Google Scholar 

  15. Heye N, Farahati J, Heinz A, Büttner T, Przuntek H, Reiners C. Topodiagnosis in Creutzfeldt-Jakob disease by HMPAO-SPECT.Nucl Med 32: 57–59, 1993.

    CAS  Google Scholar 

  16. Holthoff VA, Sandmann J, Pawlik G, Schroeder R, Heiss WD. Positron emission tomography in Creutzfeldt-Jakob disease.Arch Neurol 47: 1035–1038, 1990.

    CAS  PubMed  Google Scholar 

  17. Victoroff J, Ross GW, Benson DF, Verity MA, Vinters HV. Posterior cortical atrophy. Neuropathological correlations.Arch Neurol 51: 269–274, 1994.

    CAS  PubMed  Google Scholar 

  18. Aharon-Peretz J, Peretz A, Hemli JA, Honigman S, Israel O. SPECT diagnosis of Creutzfeldt-Jacob disease.J Nucl Med 36: 616–617, 1995.

    CAS  PubMed  Google Scholar 

  19. Goldman S, Laird A, Flament-Durant J, Luxen A, Bidaut LM, Stanus E, et al. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease.Neurology 43: 1828–1830, 1993.

    CAS  PubMed  Google Scholar 

  20. Grünwald F, Menzel C, Pavics L, Bauer J, Hufnagel A, Reichmann K, et al. Ictal and interjctai brain SPECT imaging in epilepsy using technetium-99m-ECD.J Nucl Med 35: 1896–1901, 1994.

    PubMed  Google Scholar 

  21. Silverman IE, Galetta SL, Gray LG, Moster M, Atlas SW, Maurer AH, et al. SPECT in patients with cortical visual loss.J Nucl Med 34: 1447–1451, 1993.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grünwald, F., Pohl, C., Bender, H. et al. 18F-fluorodeoxyglucose-PET and99mTc-bicisate-SPECT in Creutzfeldt-Jakob disease. Ann Nucl Med 10, 131–134 (1996). https://doi.org/10.1007/BF03165066

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03165066

Key words

Navigation